Optimized Liquid and Gas Phase Fractionation Increases HLA-Peptidome Coverage for Primary Cell and Tissue Samples is a research paper published in Molecular & Cellular Proteomics (2021). On theSindex it has a DataRank of 0.609. It has been cited 57 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.609
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: NCI-1R01CA155010
National Institutes of Health
Grant: NCI-R01 CA229261
National Institutes of Health
Grant: NCI-SPORE-2P50CA101942-11A1
National Institutes of Health
Grant: NCI-U24CA224331
National Institutes of Health
Grant: R21 CA216772-01A1
National Cancer Institute
Grant: U01 CA214125
National Cancer Institute
Grant: U24-CA210986
CDMRP
Grant: KC190128
NCI NIH HHS
Grant: U24 CA224331
NHGRI NIH HHS
Grant: T32 HG002295
NCI NIH HHS
Grant: R01 CA155010
NCI NIH HHS
Grant: R01 CA229261
NCI NIH HHS
Grant: P50 CA101942
NCI NIH HHS
Grant: R21 CA216772
NCI NIH HHS
Grant: U24 CA210986
National Institutes of Health
Grant: 5U01CA214125-03
MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS
National Institutes of Health
Grant: 5R01CA229261-02
Dissecting neoepitope-specific clonal T cell populations in advanced melanoma patients vaccinated with personal neoantigen peptides partnered with local and systemic immune checkpoint Inhibition
National Institutes of Health
Grant: 2P50CA101942-11A1
DF/HCC Kidney Cancer SPORE
National Institutes of Health
Grant: 5U24CA210986-02
Center of Excellence for High Throughput Proteogenomic Characterization
National Institutes of Health
Grant: 1R21CA216772-01A1
Physical detection of HLA-C binding peptides to identify and predict immunogenic personal neoepitopes for improving cancer vaccines
National Institutes of Health
Grant: 5R01CA155010-02
Personal tumor neoantigens for immunity against chronic lymphocytic leukemia
National Institutes of Health
Grant: 2U24CA224331-02
Cancer Immune Monitoring and Analysis Center
National Cancer Institute
CDMRP
National Institutes of Health
Fields of Study
MeSH Terms
Keywords